MedTrace Logo

Gut Microbes and Metabolic Group in Different PBC Patients for UDCA Response

NCT03590886 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2019-12-24

No results posted yet for this study

Summary

To compare intestinal flora diversity in different PBC patients with UDCA responses, and further study the differences of bile acid metabolism and short chain fatty acid metabolism in feces and serum of two groups of PBC patients.

Conditions

  • Primary Biliary Cirrhosis

Interventions

OTHER

total response Group

biochemical response for UDCA treatment more than 1 year according to Paris-I/II standard

Sponsors & Collaborators

  • Sun Yat-sen University

    lead OTHER

Principal Investigators

  • Lin B Liang, MD · Third Affliated Hospital of Sun Yat-sen University

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-22
Primary Completion
2018-12-31
Completion
2019-02-28

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03590886 on ClinicalTrials.gov